Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

VOA News Examines Malaria In Southern Sudan
VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.
generic viagra online
U.S-Mexico Border Office Chief, Dr. Maria Teresa Cerqueira Corrects Deceptive Statement About Antiviral Resistance Cases Along The Border
During a presentation about the Health Agenda for the Americas at the "Seventh
News of the day
FDA Approves TYVASO (Treprostinil) Inhalation Solution For The Treatment Of Pulmonary Arterial Hypertension
United Therapeutics Corporation (Nasdaq: UTHR) announced that the United States Food and Drug Administration (FDA) has approved TYVASO (treprostinil) Inhalation Solution for the treatment of pulmonary arterial hypertension (PAH) using the TYVASO Inhalation System (which includes the Optineb-ir device and accessories). TYVASO is indicated to increase walk distance in patients with NYHA Class III symptoms associated with WHO Group I PAH, which includes multiple etiologies such as idiopathic and familial PAH as well as PAH associated with scleroderma and congenital heart disease.
Endocrinology

Radiotherapy Link To Breast Cancer And Heart Disease Found

Scientists have found a way to identify breast cancer patients at risk of heart disease after radiotherapy, according to a report published yesterday. Radiotherapy is commonly used to treat those patients who have had breast conservation surgery, and those who are at high risk of the cancer returning after mastectomy. When the breast tumour is on the left side, a small part of the heart is within the treatment range which can lead to heart disease. Dr Paul Symonds, of the University of Leicester"s Department of Cancer Studies and Molecular Medicine, studied 149 patients who had undergone radiotherapy for breast cancer. After treatment some patients developed red dilated blood vessels (telangiectasia) on the breast or chest wall, previously thought to be unsightly rather than of any medical significance. The findings, published in the British Journal of Cancer, revealed that only those who had radiotherapy on the left side developed heart problems, which occurred between three and 12 years after treatment. Over half of those who developed heart problems showed signs of telangiectasia. These figures are significant enough to suggest that telangiectasia could be a marker to predict the risk of heart disease after radiotherapy for breast cancer on the left side. Dr Symonds is now studying the genes of 1,000 patients who have undergone radiotherapy to try and identify those likely to experience side effects which could lead to heart disease. He said, "Ultimately this research could lead to a test to predict which patients will develop severe radiotherapy side-effects. Clinicians can then use this information to advise patients of their risk before treatment and help the radiotherapist give the most appropriate treatment." Pamela Goldberg, Chief Executive, Breast Cancer Campaign, which funded the study said, "More and more women are living with breast cancer as a long term manageable condition rather than an incurable disease. It is therefore vital that treatment not only improves the chance of survival but does not lead to other negative health consequences and maintains a good quality of life." Breast Cancer Campaign


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009